(Q37863524)

English

Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinics

scientific article published on 09 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinics (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

renal cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Bruce A Feinberg

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Pradeep Jolly

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Si-Tien Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Barry Fortner

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Jeffrey Scott

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

James Gilmore

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Maureen P Neary

7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Mei Sheng Duh

8

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

9 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

786-794

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

https://scigraph.springernature.com/pub.10.1007/s12032-011-9922-z

0 references

Immunotherapy in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9922-Z

21 January 2018

Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9922-Z

21 January 2018

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9922-Z

21 January 2018

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9922-Z

21 January 2018

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9922-Z

21 January 2018

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9922-Z

21 January 2018

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9922-Z

21 January 2018

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9922-Z

21 January 2018

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9922-Z

21 January 2018

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9922-Z

21 January 2018

Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9922-Z

21 January 2018

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21479699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical treatment options in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21479699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21479699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-011-9922-Z

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37863524&oldid=2156489060"